Mercaptopurine 50-mg/mL Oral Liquid
Download in electronic PDF format for $75
Abstract: A formulation for preparing Mercaptopurine 50-mg/mL Oral Liquid. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.
Related Keywords:
mercaptopurine, Crohn's disease, inflammatory bowel disease, lymphocytic leukemia
Related Categories:
CANCER AND AIDS, FORMULATIONS, GASTROENTEROLOGY, ALLERGY/IMMUNOLOGY/INFLAMMATION, DOSAGE FORMS/DRUG CARRIERS
Printer-Friendly Version
| Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Mercaptopurine 50-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2006
Pg. 64
|
Basics of Compounding for Raynaud's Disease
Glasnapp Andrew
|
Jul/Aug 2003
Pg. 288-291
|
Treating Canine Hepatic Disease
Davidson Gigi S
|
May/Jun 2003
Pg. 188-191
|
Mercaptopurine 50 mg/mL in Ora-Sweet and Ora-Plus Suspension
Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 51
|
Mercaptopurine 75-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 234
|
Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R, Newton Gail D
|
May/Jun 2004
Pg. 181-185
|
Use of Topical Metronidazole in the Treatment of Anorectal Crohn's Disease
McElhiney Linda F
|
Sep/Oct 2013
Pg. 380-383
|
Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4
Polonini Hudson, da Silva Sharlene Loures, Brandão Marcos Antônio Fernandes, Bauters Tiene, De Moerloose Barbara, Ferreira Anderson de Oliveira
|
Nov/Dec 2018
Pg. 516-526
|
Compounding for Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases
Harrington Amy, Williams LaVonn
|
Jul/Aug 2022
Pg. 293-296
|
Basics of Compounding for Cough
Allen Loyd V Jr
|
Nov/Dec 2004
Pg. 462-465
|
Compounding for Diseases of the Oral Cavity: A discussion with Stu Sommerville, RPh
Vail Jane
|
Jan/Feb 2002
Pg. 16-18
|
Evaluation of the Stability of Mercaptopurine Suspension Compounded in a Commercial Vehicle and the Determination of an Appropriate Beyond-use Date
Peacock Gina F, Sauvageot Jurgita, Hill Ashley, Killian Alyssa
|
Jan/Feb 2016
Pg. 81-85
|
Cromolyn Sodium 50-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 336
|
Utilization of Compounded Medications in an Oral Medicine Practice
Stock Shannon, Rubino Katie, Woo Sook-Bon, Margolis Arthur, Thomas Irena, Aboalela Ali, Treister Nathaniel
|
Mar/Apr 2016
Pg. 155-158
|
Nicotinamide-Adenine Dinucleotide (NADH) in Parkinson's Disease and Alzheimer's Disease
Glasnapp Andrew, Schaefer Erin
|
Jul/Aug 2000
Pg. 276-279
|
Erythromycin 400-mg/mL and Rifampin 50-mg/mL Oral Liquid
Allen Loyd V Jr
|
Sep/Oct 2002
Pg. 367
|
Compounded Medications and Probiotics for Irritable Bowel Syndrome
Narváez Katherine Rivera, Thompson Tara
|
Sep/Oct 2022
Pg. 378-384
|
Chloral Hydrate 50-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2006
Pg. 453
|
Valacyclovir 50-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2006
Pg. 461
|
Proton Pump Inhibitor Homogenous Suspensions: A Compounding Solution to Pediatric Gastroesophageal Reflux Disease
Corsini Lindsay, Williams LaVonn A
|
Mar/Apr 2011
Pg. 124-128
|
| Return to Top |
